| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $228.7M | +23.5% |
| Cost of Revenue | $113.8M | +29.5% |
| Gross Profit | $114.9M | +18.1% |
| R&D Expense | $7.4M | +25.1% |
| SG&A Expense | $75.6M | +37.6% |
| Operating Income | $5.5M | -43.8% |
| Pre-tax Income | $7.8M | -28.6% |
| Income Tax | -$7.3M | -1874.5% |
| Net Income | $15.7M | +116.1% |
| EPS (Basic) | $0.30 | +114.3% |
| EPS (Diluted) | $0.30 | +200.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.0M | -29.5% |
| Accounts Receivable | $14.4M | +171.8% |
| Inventory | $58.6M | +43.0% |
| Current Assets | $116.6M | +15.2% |
| Total Assets | $229.8M | +31.1% |
| Current Liabilities | $39.6M | +53.7% |
| Long-term Debt | $13.2M | +734.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.2M | -42.5% |
| Capital Expenditures | $17.1M | +296.9% |
| Investing Cash Flow | -$33.6M | -368.4% |
| Financing Cash Flow | $13.4M | -65.6% |
| Free Cash Flow | -$11.9M | -349.1% |
| Total Liabilities |
| $83.2M |
| +46.0% |
| Stockholders' Equity | $146.7M | +23.7% |